Response of Lymphocyte Subsets and Cytokines to Shenyang Prescription in Sprague-Dawley Rats with Tongue Squamous Cell Carcinomas Induced by 4NQO

Overview

Journal BMC Cancer

Publisher Biomed Central

Specialty Oncology

Date 2007 Mar 7

PMID 17338814

Citations 13

Authors

Canhua Jiang

Dongxia Ye

Weiliu Qiu

Xiuli Zhang

Zhiyuan Zhang

Di He

Ping Zhang

Wantao Chen

Affiliations

Soon will be listed here.

Abstract

Background: The study was designed to investigate immunocompetence in relation to cancer progression in rat and to assess the effect of the traditional Chinese anti-cancer medicine, "Shenyang" prescription, on immunity.

Methods: 4-Nitroquinoline-1-oxide (4NQO) was administered to 80 Sprague-Dawley (SD) rats via the drinking water for up to 36 weeks. Tongue squamous cell carcinoma (SCC) was confirmed by pathological examination in 61 rats. "Shenyang" prescription was administered to subgroups of these rats, and blood samples were taken before and after treatment. Lymphocyte subsets were determined by flow cytometry. Serum Th1 and Th2-type cytokines were assessed by an enzyme-linked immunosorbent assay.

Results: As the cancer progressed at the tongue root, the percentage of CD3+CD4+ T lymphocytes and NK cells and the levels of IFN-gamma and IL-2 decreased gradually, while the percentage of CD3+CD8+ T lymphocytes and the levels of IL-4 and IL-10 increased. The CD4+/CD8+ ratios were lower in the cancer groups than in the control group. However, after administering "Shenyang" prescription, the levels of CD3+CD4+ T lymphocytes, NK cells, IFN-gamma and IL-2 increased, while the CD3+CD8+ T lymphocyte counts and the levels of IL-4 and IL-10 decreased.

Conclusion: 4NQO-induced lesions were good models for exploring oral cavity carcinogenesis. The rats with 4NQO-induced SCC demonstrated abnormalities in lymphocyte subsets and a shift from Th1-type to Th2-type, which were good models for assessing the effect of anticancer agent on immunity. Oral cancer progression was associated with an aggressive disturbance of immune function. "Shenyang" prescription has the ability to improve the disturbance of immune function.

Citing Articles

Noni enhances the anticancer activity of cyclophosphamide and suppresses myelotoxicity and hepatotoxicity in tumor-bearing mice.

Ali M, Manjula S, Mohiuddin I, Mruthunjaya K, Shakeel F, Mir S J Cancer Res Clin Oncol. 2024; 150(4):212.

PMID: 38662247 PMC: 11045611. DOI: 10.1007/s00432-024-05734-1.

Identification and Confirmation of the miR-30 Family as a Potential Central Player in Tobacco-Related Head and Neck Squamous Cell Carcinoma.

Zhang T, Zhu X, Sun Q, Qin X, Zhang Z, Feng Y Front Oncol. 2021; 11:616372.

PMID: 34336638 PMC: 8315965. DOI: 10.3389/fonc.2021.616372.

The Microenvironment of Tongue Cancer.

Tao W, Li-Juan Z, Kan L, Jing-Yuan L, Xiang-Qi L, Yu-Jie L Adv Exp Med Biol. 2021; 1296:49-78.

PMID: 34185286 DOI: 10.1007/978-3-030-59038-3_4.

Salivary cytokines as biomarkers of oral cancer: a systematic review and meta-analysis.

Chiamulera M, Zancan C, Remor A, Cordeiro M, Gleber-Netto F, Baptistella A BMC Cancer. 2021; 21(1):205.

PMID: 33639868 PMC: 7912500. DOI: 10.1186/s12885-021-07932-3.

TLR2 deficiency enhances susceptibility to oral carcinogenesis by promoting an inflammatory environment.

Li B, Hou D, Xu S, Zhang J, Zhu L, Wang Q Am J Cancer Res. 2020; 9(12):2599-2617.

PMID: 31911849 PMC: 6943345.

References

Chen Z, Malhotra P, Thomas G, Ondrey F, Duffey D, Smith C . Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res. 1999; 5(6):1369-79. View

Hawkins B, Heniford B, Ackermann D, Leonberger M, Martinez S, Hendler F . 4NQO carcinogenesis: a mouse model of oral cavity squamous cell carcinoma. Head Neck. 1994; 16(5):424-32. DOI: 10.1002/hed.2880160506. View

Lippman S, Sudbo J, Hong W . Oral cancer prevention and the evolution of molecular-targeted drug development. J Clin Oncol. 2005; 23(2):346-56. DOI: 10.1200/JCO.2005.09.128. View

Huang D, Ran R, Yu Z . [Effect of Acanthopanax senticosus injection on the activities of human tumor necrosis factor and natural killer cell in blood in the patients with lung cancer]. Zhongguo Zhong Yao Za Zhi. 2005; 30(8):621-4. View

van Sandick J, Boermeester M, Gisbertz S, Ten Berge I, Out T, van der Pouw Kraan T . Lymphocyte subsets and T(h)1/T(h)2 immune responses in patients with adenocarcinoma of the oesophagus or oesophagogastric junction: relation to pTNM stage and clinical outcome. Cancer Immunol Immunother. 2003; 52(10):617-24. PMC: 11034314. DOI: 10.1007/s00262-003-0406-7. View

Kuninaka S, Yano T, Yokoyama H, Fukuyama Y, Terazaki Y, Uehara T . Direct influences of pro-inflammatory cytokines (IL-1beta, TNF-alpha, IL-6) on the proliferation and cell-surface antigen expression of cancer cells. Cytokine. 2000; 12(1):8-11. DOI: 10.1006/cyto.1998.0504. View

Nishimura T, Nakui M, Sato M, Iwakabe K, Kitamura H, Sekimoto M . The critical role of Th1-dominant immunity in tumor immunology. Cancer Chemother Pharmacol. 2000; 46 Suppl:S52-61. DOI: 10.1007/pl00014051. View

Liss C, Fekete M, Hasina R, Lam C, Lingen M . Paracrine angiogenic loop between head-and-neck squamous-cell carcinomas and macrophages. Int J Cancer. 2001; 93(6):781-5. DOI: 10.1002/ijc.1407. View

Liu X, He R, Chen W . [A rat model of tongue mucosa squamous cell carcinoma induced by oral administration of 4NQO in drinking water]. Zhonghua Kou Qiang Yi Xue Za Zhi. 2002; 34(6):354-6. View

10.

Kaplan I, Hochstadt T, Dayan D . PCNA in palate and tongue mucosal dysplastic lesions induced by topically applied 4NQO in desalivated rat. Med Oral. 2002; 7(5):336-43. View

11.

Agarwal A, Rani M, Saha G, Valarmathi T, Bahadur S, Mohanti B . Disregulated expression of the Th2 cytokine gene in patients with intraoral squamous cell carcinoma. Immunol Invest. 2003; 32(1-2):17-30. DOI: 10.1081/imm-120019205. View

12.

Tang X, Knudsen B, Bemis D, Tickoo S, Gudas L . Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice. Clin Cancer Res. 2004; 10(1 Pt 1):301-13. DOI: 10.1158/1078-0432.ccr-0999-3. View

13.

Gannot G, Buchner A, Keisari Y . Interaction between the immune system and tongue squamous cell carcinoma induced by 4-nitroquinoline N-oxide in mice. Oral Oncol. 2004; 40(3):287-97. DOI: 10.1016/j.oraloncology.2003.08.008. View

14.

Ha E, Hwang S, Shin K, Yu K, Lee K, Choi J . Anti-metastatic activity of glycoprotein fractionated from Acanthopanax senticosus, involvement of NK-cell and macrophage activation. Arch Pharm Res. 2004; 27(2):217-24. DOI: 10.1007/BF02980109. View

15.

Lathers D, Young M . Increased aberrance of cytokine expression in plasma of patients with more advanced squamous cell carcinoma of the head and neck. Cytokine. 2004; 25(5):220-8. DOI: 10.1016/j.cyto.2003.11.005. View

16.

Kuss I, Hathaway B, Ferris R, Gooding W, Whiteside T . Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck. Clin Cancer Res. 2004; 10(11):3755-62. DOI: 10.1158/1078-0432.CCR-04-0054. View

17.

Ribeiro D, Salvadori D, da Silva R, Ribeiro Darros B, Marques M . Genomic instability in non-neoplastic oral mucosa cells can predict risk during 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis. Oral Oncol. 2004; 40(9):910-5. DOI: 10.1016/j.oraloncology.2004.04.010. View

18.

Wallenius K, Lekholm U . Oral cancer in rats induced by the water-soluble carcinogen 4-nitrochinoline N-oxide. Odontol Revy. 1973; 24(1):39-48. View

19.

Watson G, Lopez D . Aberrant antigen presentation by macrophages from tumor-bearing mice is involved in the down-regulation of their T cell responses. J Immunol. 1995; 155(6):3124-34. View

20.

van den Broek M, Kagi D, Zinkernagel R, Hengartner H . Perforin dependence of natural killer cell-mediated tumor control in vivo. Eur J Immunol. 1995; 25(12):3514-6. DOI: 10.1002/eji.1830251246. View